New products include the Hematek 3000 hematology analyzer from Siemens Healthcare Diagnostics, CoolCell alcohol-free cell-freezing containers from Biocision, and the Prostate Health Index from Beckman Coulter Diagnostics.
Read More
The National Comprehensive Cancer Network has recommended the Beckman Coulter Prostate Health Index (PHI) as a blood test that can improve specificity for prostate cancer detection and reduce the need for unnecessary biopsies.
Read More
The Prostate Health Index from Beckman Coulter Diagnostics minimizes the need for men with elevated PSA levels to undergo biopsy to achieve an accurate diagnosis.
Read MoreData from the Procede 500 study of cell-cycle progression testing with the Prolaris RNA-expression test indicate that 65% of physicians changed their original treatment plans for men with prostate cancer based on results from the test.
Read MoreA newly published study of a molecular diagnostic test by Myriad Genetics has demonstrated that the test can accurately predict which men will develop biochemical recurrence or metastatic disease following radical prostate surgery.
Read More